Showing results (2201-2210 of 8,257) with videos related to

Sort By:
Pageof 826
Haematologica|March 9, 2019
Christmas disease in a Hovawart family resembling human hemophilia B Leyden is caused by a single nucleotide deletion in a highly conserved transcription factor binding site of the F9 gene promoterBertram Brenig, Lilith Steingräber, Shuwen Shan, et al.
Haematologica|February 11, 2021
Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregatesMartina H Lundberg Slingsby, Prakrith Vijey, I-Ting Tsai, et al.
Haematologica|February 11, 2021
Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysisRachel Dobson, Peter Y Du, Lívia Rásó-Barnett, et al.
Haematologica|February 11, 2021
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromesNathalie Van Leeuwen-Kerkhoff, Theresia M Westers, Pino J Poddighe, et al.
Haematologica|February 11, 2021
Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxiaOsheiza Abdulmalik, Noureldien H E Darwish, Vandhana Muralidharan-Chari, et al.
Haematologica|March 18, 2017
Improved survival after acute graft-versus-host disease diagnosis in the modern eraHanna J Khoury, Tao Wang, Michael T Hemmer, et al.
Haematologica|February 4, 2021
Mobilization efficiency is critically regulated by fat via marrow PPARδTomohide Suzuki, Shinichi Ishii, Masakazu Shinohara, et al.
Haematologica|August 16, 2019
IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplificationPhaik Ju Teoh, Tae-Hoon Chung, Pamela Y Z Chng, et al.
Haematologica|August 16, 2019
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic womenNicole U Stoffel, Christophe Zeder, Gary M Brittenham, et al.
Haematologica|August 16, 2019
Emerging disease-modifying therapies for sickle cell diseaseMarcus A Carden, Jane Little
Pageof 826